Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: a modelling study (2023)

First Author: Qian G
Attributed to:  MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.02.22.23286294

Publication URI: http://dx.doi.org/10.1101/2023.02.22.23286294

Type: Preprint